初始神经系统状态良好的动脉瘤性蛛网膜下腔出血患者预后不良的危险因素
该研究纳入2003年1月至2016年6月在本院连续治疗的初始世界神经外科医师联盟分级I-III级的动脉瘤性蛛网膜下腔出血患者582例,分析人口学、病史、出血严重程度与6个月功能预后。脑梗死、院内死亡和6个月预后不良发生率分别为35.1%、8.1%和17.6%。
要点
- 初始分级I-III级的动脉瘤性蛛网膜下腔出血患者中,脑梗死发生率为35.1%,但超过80%患者长期预后良好。
- 急性脑积水、动脉瘤夹闭术和联合使用钙通道阻滞剂与尼莫地平独立增加脑梗死风险。
- 年龄>55岁、急性脑积水和夹闭术预测院内死亡;年龄、Fisher分级III-IV级、急性脑积水、夹闭术、入院C反应蛋白>1mg/dL及治疗间隔与6个月预后不良相关。
核心结论
- 尽管脑梗死是初始临床状况良好的动脉瘤性蛛网膜下腔出血患者的常见并发症,但超过80%的患者长期预后良好。
- 了解与预后相关的基线特征可能有助于减轻初始出血耐受良好患者的进一步并发症和不良预后负担。
研究设计与样本
- 连续纳入2003年1月至2016年6月在本院治疗的初始世界神经外科医师联盟分级I-III级的动脉瘤性蛛网膜下腔出血患者,最终队列582例。
- 收集人口学特征、既往病史、初始动脉瘤性蛛网膜下腔出血严重程度及功能预后数据。
- 研究终点为脑梗死发生、院内死亡和动脉瘤性蛛网膜下腔出血后6个月预后不良(改良Rankin量表>3分)。
主要发现
- 最终队列582例中,脑梗死、院内死亡和预后不良发生率分别为35.1%、8.1%和17.6%。
- 脑梗死风险独立相关因素:急性脑积水(校正比值比[aOR]=2.33,p<0.0001)、动脉瘤夹闭术(aOR=1.78,p=0.003)、联合使用钙通道阻滞剂与尼莫地平(aOR=2.63,p=0.002)。
- 院内死亡预测因素:年龄>55岁(aOR=4.24,p<0.0001)、急性脑积水(aOR=2.43,p=0.036)、夹闭术(aOR=2.86,p=0.001)。
- 6个月预后不良相关基线特征:年龄(aOR=2.77,p<0.0001)、Fisher分级III-IV级(aOR=2.81,p=0.016)、急性脑积水(aOR=2.22,p=0.012)、夹闭术(aOR=3.98,p<0.0001)、入院C反应蛋白>1mg/dL(aOR=1.76,p=0.035)、治疗间隔(每5年间隔aOR=0.64,p=0.006)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Aneurysmal subarachnoid hemorrhage (aSAH) remains a devastating diagnosis. A poor outcome is known to be highly dependent on the initial neurological status. Our goal was to identify other parameters that favor the risk of complications and poor outcome in patients with aSAH and initially favorable neurologic status. METHODS: Consecutive aSAH cases treated at our hospital between 01/2003 and 06/2016 with the initial World Federation of Neurosurgical Societies grades I-III were included. Data on demographic characteristics, previous medical history, initial aSAH severity, and functional outcome after aSAH were collected. The study endpoints were the occurrence of cerebral infarcts, in-hospital mortality, and unfavorable outcome at 6 months after aSAH (modified Rankin scale > 3). RESULTS: In the final cohort (n= 582), the rate of cerebral infarction, in-hospital mortality, and unfavorable outcome was 35.1%, 8.1%, and 17.6% respectively. The risk of cerebral infarction was independently related to the presence of acute hydrocephalus (adjusted odds ratio [aOR]=2.33, p<0.0001), aneurysm clipping (aOR=1.78, p=0.003), and use of calcium channel blockers concomitant to nimodipine (aOR=2.63, p=0.002). Patients' age (>55 years, aOR=4.24, p<0.0001), acute hydrocephalus (aOR=2.43, p=0.036), and clipping (aOR=2.86, p=0.001) predicted in-hospital mortality. Baseline characteristics associated with unfavorable outcome at 6 months were age (aOR=2.77, p=<0.0001), Fisher grades III-IV (aOR=2.81, p=0.016), acute hydrocephalus (aOR=2.22, p=0.012), clipping (aOR=3.98, p<0.0001), admission C-reactive protein>1mg/dL (aOR=1.76, p=0.035), and treatment intervals (aOR=0.64 per-5-year-intervals, p=0.006). CONCLUSIONS: Although cerebral infarction is a common complication in aSAH individuals with favorable initial clinical condition, >80% of these patients show favorable long-term outcome. The knowledge of outcome-relevant baseline characteristics might help to reduce the burden of further complications and poor outcome in aSAH patients who tolerated the initial bleeding event well.
引用
- Lenkeit A, Oppong MD, Dinger TF, et al. Risk factors for poor outcome after aneurysmal subarachnoid hemorrhage in patients with initial favorable neurological status. Acta Neurochir (Wien). 2024. PMID: 38376665. doi:10.1007/s00701-024-05968-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。